Literature DB >> 19953642

Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia type1 (MEN1).

Jeremy J O Turner1, Paul T Christie, Simon H S Pearce, Peter D Turnpenny, Rajesh V Thakker.   

Abstract

Phenocopies may confound the clinical diagnoses of hereditary disorders. We report phenocopies in Multiple Endocrine Neoplasia type 1 (MEN1), an autosomal dominant disorder, characterised by the combined occurrence of parathyroid, pituitary and pancreatic tumours. We studied 261 affected individuals from 74 families referred with a clinical diagnosis of MEN1 and sought inconsistencies between the mutational and clinical data. We identified four patients from unrelated families with phenocopies. Patients 1 and 2 from families with MEN1, developed prolactinomas as the sole endocrinopathy but they did not harbour the germline MEN1 mutation present in their affected relatives. Patient 3, had acromegaly and recurrent hypercalcaemia following parathyroidectomy, whilst patient 4 had parathyroid tumours and a microprolactinoma. Patients 3 and 4 and their relatives did not have MEN1 mutations, but instead had familial hypocalciuric hypercalcaemia (FHH) due to a calcium-sensing receptor mutation (p.Arg680Cys), and the hyperparathyroidism-jaw tumour (HPT-JT) syndrome due to a hyperparathyroidism type 2 deletional-frameshift mutation (c.1239delA), respectively. Phenocopies may mimic MEN1 either by occurrence of a single sporadic endocrine tumour in a patient with familial MEN1, or occurrence of two endocrine abnormalities associated with different aetiologies. Phenocopies arose in >5% of MEN1 families, and awareness of them is important in the clinical management of MEN1 and other hereditary disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19953642     DOI: 10.1002/humu.21170

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  20 in total

Review 1.  Clinical aspects of multiple endocrine neoplasia type 1.

Authors:  Abdallah Al-Salameh; Guillaume Cadiot; Alain Calender; Pierre Goudet; Philippe Chanson
Journal:  Nat Rev Endocrinol       Date:  2021-02-09       Impact factor: 43.330

Review 2.  Genetic test in multiple endocrine neoplasia type 1 syndrome: An evolving story.

Authors:  Francesca Marini; Francesca Giusti; Maria Luisa Brandi
Journal:  World J Exp Med       Date:  2015-05-20

Review 3.  Molecular genetics in primary hyperparathyroidism: the role of genetic tests in differential diagnosis, disease prevention strategy, and therapeutic planning. A 2017 update.

Authors:  Francesca Marini; Luisella Cianferotti; Francesca Giusti; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2017-05-30

4.  Impact of a novel 14 bp MEN1 deletion in a patient with hyperparathyroidism and gastrinoma.

Authors:  Shweta Birla; Viveka P Jyotsna; Rajiv Singla; Madhavi Tripathi; Arundhati Sharma
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-04-29

5.  Multiple Endocrine Neoplasia Type 1 Presenting as Hypoglycemia due to Insulinoma.

Authors:  Eun Byul Kwon; Hwal Rim Jeong; Young Seok Shim; Hae Sang Lee; Jin Soon Hwang
Journal:  J Korean Med Sci       Date:  2016-04-11       Impact factor: 2.153

6.  Multiple endocrine neoplasia phenocopy revealed as a co-occurring neuroendocrine tumor and familial hypocalciuric hypercalcemia type 3.

Authors:  Silje Hovden; Marie Louise Jespersen; Peter H Nissen; Per Løgstrup Poulsen; Lars Rolighed; Søren A Ladefoged; Lars Rejnmark
Journal:  Clin Case Rep       Date:  2016-08-18

Review 7.  Multiple Endocrine Neoplasia Type 1: Latest Insights.

Authors:  Maria Luisa Brandi; Sunita K Agarwal; Nancy D Perrier; Kate E Lines; Gerlof D Valk; Rajesh V Thakker
Journal:  Endocr Rev       Date:  2021-03-15       Impact factor: 19.871

8.  Multiple endocrine neoplasia type 1.

Authors:  R V Thakker
Journal:  Indian J Endocrinol Metab       Date:  2012-12

9.  MEN4, the MEN1 Mimicker: A Case Series of three Phenotypically Heterogenous Patients With Unique CDKN1B Mutations.

Authors:  Amanda Seabrook; Ayanthi Wijewardene; Sunita De Sousa; Tang Wong; Nisa Sheriff; Anthony J Gill; Rakesh Iyer; Michael Field; Catherine Luxford; Roderick Clifton-Bligh; Ann McCormack; Katherine Tucker
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

Review 10.  Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).

Authors:  Rajesh V Thakker
Journal:  Mol Cell Endocrinol       Date:  2013-08-08       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.